GlassScriptPhysician profile
Timothy Michael Hodges
NPI 1679676795
$641.35
in general payments reported to CMS, 2019-2025
11 companies · $32.20 in 2025
The $32.20 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $48.45 · 2021: $129 · 2022: $115 · 2023: $76.27 · 2024: $44.39 · 2025: $32.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $162.09 | 2019 | |
| Allergan, INC. | $105.27 | 2020-2022 | |
| Ethicon US, LLC | $81.46 | 2021-2024 | Stratafix, Ethicon |
| Baxter Healthcare | $79.61 | 2020-2022 | |
| Davol INC. | $56.03 | 2022-2025 | Phasix Mesh |
| Medtronic, INC. | $52.90 | 2023 | Endoflip |
| Conmed Corporation | $28.19 | 2021 | |
| Shionogi INC | $23.37 | 2023 | Fetroja |
| Abbott Laboratories | $18.93 | 2020 | |
| Shire North American Group INC | $17.55 | 2019 | |
| Tei Biosciences INC | $15.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.